汉森制药：公司始终高度重视股东回报

Core Viewpoint - Hansen Pharmaceutical (002412) emphasizes its commitment to shareholder returns and ensures that related decisions strictly adhere to legal regulations and the company's articles of association [1] Group 1 - The company actively engages with investors through interactive platforms to address their inquiries [1] - Hansen Pharmaceutical maintains a strong focus on compliance with laws and regulations in its decision-making processes [1] - The company prioritizes shareholder interests in its operational strategies [1]